A phase 2 Study Evaluating the Efficacy and Safety of Single Agent AUR103 Calcium in Patients with Advanced, Well or Moderately differentiated Neuroendocrine T…

Neuroendocrine (NE) TumorsAdvanced NET of GI Origin

~Estimated

~$10 – $8,750

Aurigene Discovery Technologies LimitedNCT07640737

Phase 2

Evaluation of Ultralow Dose PET Imaging for Detecting SSTR2 Radiotracer Uptake

The goal of this clinical trial is to evaluate an investigational ultralow dose positron emission tomography (PET) imaging technique for neuroendocrine tumor d…

Healthy (Controls)Healthy VolunteersNeuroendocrine (NE) Tumors

~Estimated

~$10 – $7,500

Akiva MintzNCT07284589

A Prospective Observational Study on Genomic and Methylation Signatures in Patients with Extensive-Stage Small Cell Lung Cancer and Metastatic Large Cell Neuroendocrine Carcinoma Undergoing Chemo-Immunotherapy

The goal of this observational study is to understand how genomic and epigenetic factors contribute to resistance against chemo-immunotherapy in adults diagnos…

Small Cell Lung CancerLarge Cell Neuroendocrine (NE) TumorsTreatment Failure+3 more

~Estimated

~$10 – $1,125

Oncology Center of Biochemical Education And ResearchNCT06717243